EICHORCondition: Locally Advanced Unresectable or Metastatic Solid Tumors · Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This is a Phase Ia/Ib, multicenter, open-label, first-in-human study to evaluate the safety, tolerability, PK, and efficacy of IBI343 in participants with locally advanced unresectable or metastatic solid tumors. It is planned to be carried out in different countries or regions such as China, Australia and US. There are three parts in phase Ia. Part 1 includes dose escalation and expansion phase and part 2 is designed for dose optimization for IBI343 monotherapy. Part 3 1L G/GEJ AC and 1L PDAC cohorts will include an initial safety lead-in stage to confirm the tolerability of IBI343 in combination with chemotherapy in 1L PDAC and G/GEJ AC, followed by a randomized dose-optimization stage designed to further characterize safety, pharmacokinetics, and preliminary efficacy to inform selection of the recommended Phase 3 dose.
This description comes directly from the study's public registry record.
Suhua Dong · 0512-69566088 · suhua.dong@innoventbio.com
Always discuss trial participation with your own doctor first.
| Next Oncology-Austin | Austin, Texas, United States | Recruiting |
| Next Oncology-Dallas | Irving, Texas, United States | Recruiting |
| Next Oncology-San Antonio | San Antonio, Texas, United States | Recruiting |
| St Vincent's Hospital Sydney | Darlinghurst, New South Wales, Australia | Recruiting |
| Cancer Care Wollongong | Wollongong, New South Wales, Australia | Recruiting |
| Pindara Private Hospital | Benowa, Queensland, Australia | Active Not Recruiting |
| Sunshine Coast University Private Hospital | Birtinya, Queensland, Australia | Recruiting |
| Anhui Cancer Hospital | Hefei, Anhui, China | Recruiting |
| Anhui Provincial Hospital | Hefei, Anhui, China | Recruiting |
| The First Affiliated Hospital of Wannan Medical College | Wuhu, Anhui, China | Recruiting |
| Beijing Cancer Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Tumor Hospital, Chinese Academy of Medical Sciences | Beijing, Beijing Municipality, China | Recruiting |
+ 27 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05458219